BOLD NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Boundless Bio, Inc. Common Stock · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 2.50 USD
-2.7% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 62.8% above the Trend Line and sits at 84.1% of its 52-week range. The latest completed week returned -2.7%, after a 0.0% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 55/100. Near-term considerations: volume confirmation is below normal; earnings are due in 2d.

Setup score 58 out of 100
Latest Close 2.50 USD 31 Jul 2026
1W Return -2.7% latest completed week
4W Return 0.0% short-term follow-through
12W Return 73.6% quarterly tape
Trend Breadth 38.5% 20 of 52 weeks active
Volume Ratio 0.1x vs 13-week average
What is working
  • The trend backdrop is active with a 14-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Recent volatility is running well above the one-year baseline.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -2.7% Latest completed week; four-week move 0.0%. Indicator stack 66/81 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 55/100 63 relevant articles in the latest sentiment read. Event risk 2d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 62.8% above the Trend Line and sits at 84.1% of its 52-week range. The latest completed week returned -2.7%, after a 0.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.1x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8812-week average 0.71

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership7/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.88Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 0.0% over four weeks, 73.6% over 12 weeks, and 115.5% over one year. The current trend has remained active for 14 consecutive weeks.

Performance by holding period

1W-2.7%
4W0.0%
12W73.6%
26W115.5%
52W115.5%
Active trend streak14 weeks
Active weeks in one year20
Trend breadth38.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.60Latest activity-pressure read.
Pressure change27.4%Four-week change in activity pressure.
Leadership65.99Latest relative-leadership reading.
RS change-3.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 67% Model confidence 64%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength69/100Blend of value, momentum, and quality. Underlying universe rank 32; rank 1 is best.
Value59/100Relative valuation strength. Underlying universe rank 42; rank 1 is best.
Quality57/100Profitability and accounting quality. Underlying universe rank 44; rank 1 is best.
Momentum59/100Medium-term price momentum. Underlying universe rank 42; rank 1 is best.
Growth59/100Revenue and earnings growth. Underlying universe rank 42; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-52.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-
Free cash flow generated from revenue.
Return on invested capital
-35.8%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
1/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment55/100

Weighted news tone is neutral across 63 relevant articles.

20 positive · 40 neutral · 3 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings2dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-10.4%Distance below the 52-week high.
13-week volatility21.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2613 weeks finished lower.
Best week+79.0%Week of 26 Jun.
Worst week-8.3%Week of 8 May.
Latest week-2.7%Week of 31 Jul.

Shape of recent returns

Strong gains5
Modest gains6
Flat weeks2
Modest losses10
Sharp losses3
Recent vol21.5%13-week weekly-return volatility.
Base vol12.9%52-week weekly-return volatility.
Up/down split25/23Count of positive and negative weeks in the 52-week window.
Average skew8.3% / -4.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape56/100

Trend, activity pressure, participation, and risk combine to a 56/100 tape read.

 Indicator analysis82/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 7/12.

Activity pressure 0.88; No reversal markers Factors60/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 47; Small Cap Core rank 49 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Sentiment55/100

Weighted news tone is neutral across 63 relevant articles.

Prediction: Chevron's Bold Moves in Iraq Will Reshape the Oil Stock Over the Next Decade. Insiders50/100

No recent insider transaction evidence is stored.

 Earnings2d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20262.50 USD-2.7%1.54 USD2.77 USD1.6065.99535.6KOn
24 Jul 20262.57 USD3.6%1.49 USD2.77 USD1.7073.911.0MOn
17 Jul 20262.48 USD2.9%1.45 USD2.77 USD1.8467.40989.1KOn
10 Jul 20262.41 USD-3.6%1.41 USD2.77 USD1.5557.911.2MOn
3 Jul 20262.50 USD-2.3%1.36 USD2.78 USD1.2668.571.4MOn
26 Jun 20262.56 USD79.0%1.32 USD2.78 USD0.9776.6868.7MOn
19 Jun 20261.43 USD1.4%1.27 USD2.78 USD0.66-4.16309.5KOn
12 Jun 20261.41 USD-0.7%1.26 USD2.79 USD0.78-3.02289.0KOn
5 Jun 20261.42 USD-2.1%1.26 USD2.80 USD0.96-0.12366.0KOn
29 May 20261.45 USD0.7%1.25 USD2.82 USD1.10-2.81253.3KOn
22 May 20261.44 USD-3.4%1.25 USD2.83 USD1.24-0.84459.9KOn
15 May 20261.49 USD3.5%1.25 USD2.84 USD1.372.851.2MOn
8 May 20261.44 USD-8.3%1.25 USD2.85 USD1.51-1.91714.0KOn
1 May 20261.57 USD4.7%1.24 USD2.87 USD1.1511.85417.3KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.